Dyadic, Sanofi Pasteur, EnGen Bio ink R&D deal
In the Netherlands, the Dutch-based R&D subsidiary of Dyadic International has entered into an research agreement with Sanofi Pasteur, the vaccines division of sanofi-aventis Group, and EnGen Bio, Inc. Under the agreement, Sanofi Pasteur will fund collaborative research at Dyadic Netherland’s research and development facility in Wageningen, The Netherlands, which will utilize Dyadic’s proprietary and […]














